A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Clinical trial NCT06723652 · COMPLETED
Trial details
- NCT number
- NCT06723652
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-13
- Primary completion
- 2025-08-25
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.